Intercept Pharmaceuticals (ICPT) Down with FDA Recommendations

Intercept Pharmaceuticals Inc ICPT shares slid 4.7% to $156.17 after the company announced the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee voted to recommend Ocaliva. Share volume was 2.2 million, compared to an all-day average of 692,000